Revolution Medicines · 1 month ago
Director, Medical Science Liaison (Boston, RI, NH, VT, ME)
United States
Full-time
Remote
Director/Executive
$194K/yr - $242K/yr
8+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Medical Science Liaison will engage with healthcare professionals, provide scientific support, and build relationships with key opinion leaders to advance scientific and medical knowledge.
Health CareLife ScienceMedical
Responsibilities
Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge
Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions
Support the synthesis and communicate scientific insights from KOLs to relevant internal teams
Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities
Establish credibility as a scientific expert and resource for internal stakeholders, providing medical and scientific support for products and therapeutic areas
Collaborate cross-functionally with medical affairs, clinical development, marketing and other teams to support the development and execution of medical strategies and tactics
Stay current with scientific literature, emerging research, and competitive landscape
Adhere to Revolution Medicines Core Values and policies
Understand the regulatory requirements for customer engagement by field-based employees
Qualification
Required
Doctoral degree in scientific or medical discipline
8+ years experience as an MSL or in a similar role within the pharmaceutical or biotech industry
Strong understanding of clinical research methodologies and drug development processes
Knowledge and experience within the oncology therapeutic area
Excellent verbal and written communication skills
Proven ability to analyze and synthesize scientific information effectively
Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences
Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals
Self-directed and able to thrive in a fast-paced and dynamic environment
Willingness to travel up to 60% of time
Preferred
Preferred experience in lung and gastrointestinal cancers
Experience with both early and late stage clinical assets as well as approved therapies
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
Pharmaceutical Technology
2026-01-13
Company data provided by crunchbase